KEDRAB: payments to doctors
Payments that named KEDRAB as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $371K
- Providers
- 1,377
- Transactions
- 2,040
- Average per transaction
- $182
The per-transaction average — $182 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,377 providers the average total is $270, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Kedrion Biopharma, Inc. | $267,557 | 72.1% |
| Kedrion Biopharma Inc. | $103,732 | 27.9% |